Evidence map›Paper›PMID 31263149›Full record

ArticleScientific reports2019

Intensity Modulated Radiation Fields Induce Protective Effects and Reduce Importance of Dose-Rate Effects.

Yusuke Matsuya, Stephen J McMahon, Mihaela Ghita, Yuji Yoshii, Tatsuhiko Sato, Hiroyuki Date, Kevin M Prise

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Improved dose compensation model owing to short irradiation interruption time for hypoxic tumor using a microdosimetric kinetic model.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2024
    Article
  4. Article
  5. Biological dosimetric impact of dose-delivery time for hypoxic tumour with modified microdosimetric kinetic model.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yusuke MatsuyaJapan Atomic Energy Agency (JAEA), Nuclear Science and Engineering Center, Research Group for Radiation Transport Analysis, 2-4 Shirakata, Tokai, 319-1195, Ibaraki, Japan. y-matsuya1028@frontier.hokudai.ac.jp.
Stephen J McMahonCentre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Road, BT7 9AE, Belfast, UK.ORCID http://orcid.org/0000-0001-5980-6728
Mihaela GhitaCentre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Road, BT7 9AE, Belfast, UK.ORCID http://orcid.org/0000-0002-2467-9156
Yuji YoshiiBiological Research, Education and Instrumentation Center, Sapporo Medical University, Minami-1 Nishi-17, Chuo-ku, Sapporo, 060-8556, Hokkaido, Japan.
Tatsuhiko SatoJapan Atomic Energy Agency (JAEA), Nuclear Science and Engineering Center, Research Group for Radiation Transport Analysis, 2-4 Shirakata, Tokai, 319-1195, Ibaraki, Japan.
Hiroyuki DateFaculty of Health Sciences, Hokkaido University, Kita-12 Nishi-5, Kita-ku, Sapporo, 060-0812, Hokkaido, Japan.
Kevin M PriseCentre for Cancer Research and Cell Biology, Queen's University Belfast, 97 Lisburn Road, BT7 9AE, Belfast, UK.ORCID http://orcid.org/0000-0001-6134-7946

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In advanced radiotherapy, intensity modulated radiation fields and complex dose-delivery are utilized to prescribe higher doses to tumours. Here, we investigated the impact of modulated radiation fields on radio-sensitivity and cell recovery during dose delivery. We generated experimental survival data after single-dose, split-dose and fractionated irradiation in normal human skin fibroblast cells (AGO1522) and human prostate cancer cells (DU145). The dose was delivered to either 50% of the area of a T25 flask containing the cells (half-field) or 100% of the flask (uniform-field). We also modelled the impact of dose-rate effects and intercellular signalling on cell-killing. Applying the model to the survival data, it is found that (i) in-field cell survival under half-field exposure is higher than uniform-field exposure for the same delivered dose; (ii) the importance of sub-lethal damage repair (SLDR) in AGO1522 cells is reduced under half-field exposure; (iii) the yield of initial DNA lesions measured with half-field exposure is smaller than that with uniform-field exposure. These results suggest that increased cell survival under half-field exposure is predominantly attributed not to rescue effects (increased SLDR) but protective effects (reduced induction of initial DNA lesions). In support of these protective effects, the reduced DNA damage leads to modulation of cell-cycle dynamics, i.e., less G

Indexed as

DNA DamageDose Fractionation, RadiationProstatic NeoplasmsCell Line, TumorCell SurvivalDNA, NeoplasmDose-Response Relationship, RadiationHumansMaleDNA, Neoplasm

Identifiers

PMID31263149
PMCPMC6603191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.